John Rim, Samsung Biologics CEO

Sam­sung Bi­o­log­ics moves up plans to open its $1.5B+ plant

Sam­sung Bi­o­log­ics, the con­tract man­u­fac­tur­ing arm of the South Ko­re­an-based con­glom­er­ate Sam­sung, plans to open the doors to one of its fac­to­ries a lit­tle soon­er than ex­pect­ed.

On Tues­day, Sam­sung Bi­o­log­ics an­nounced that it plans to have its fifth man­u­fac­tur­ing plant op­er­a­tional at its Song­do site in South Ko­rea by April 2025. The plant, in­to which Sam­sung Bi­o­log­ics is in­vest­ing more than KRW 1.8 tril­lion (about $1.5 bil­lion), is slat­ed to break ground lat­er this year. The fa­cil­i­ty will be 96,000 square me­ters, or around 1 mil­lion square feet.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.